LINC01332

Across TCGA pan-cancer cohorts, LINC01332 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated LINC01332 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher LINC01332 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01332 expression acts as an unfavorable survival marker.

BLCA, ESCA, and UCS are the cancer types where LINC01332 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.388	0.717	<.001	144	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	54	view →
UCS	OS	Tertile	III,IV	0.274	0.636	.005	54	view →
CESC	DFS	Tertile	II,III,IV	0.495	0.788	.009	18	view →
HNSC	OS	Tertile	IV	0.042	0.653	<.001	18	view →
LIHC	OS	Tertile	III,IV	0.059	0.738	<.001	18	view →
BRCA	OS	Tertile	III,IV	0.772	0.913	.033	12	view →
SKCM	OS	Tertile	IV	0.179	0.727	<.001	9	view →
THCA	DFS	Tertile	II,III,IV	0.133	0.764	.040	9	view →
READ	DFS	Tertile	IV	0.095	0.697	.014	9	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

LINC01332–BLCA (OS)

Open the BLCA breakdown →